Publications in collaboration with researchers from Harvard Medical School (2)

2021

  1. COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 5, pp. 2083-2086

  2. GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

    Blood, Vol. 138, Núm. 17, pp. 1590-1602